Li Zi-Chao, Cai Hong-Bin, Fan Zhen-Zhen, Zhai Xiao-Bin, Ge Zhao-Ming
Department of Neurology, Lanzhou University Second Hospital, Lanzhou 730000, Gansu Province, China.
World J Clin Cases. 2022 May 6;10(13):4190-4195. doi: 10.12998/wjcc.v10.i13.4190.
Paraneoplastic neurological syndrome (PNS) is a rare complication in patients with cancer. PNS can affect the central, peripheral, autonomic nervous system, neuromuscular junction, or muscles and cause various neurological symptoms. Anti-Yo antibody-positive neurological paraneoplasms and anti-Hu antibody-positive neurological paraneoplasms are common, but coexistence of both types has not been described in the literature.
Here we present a rare case of paraneoplastic neuropathy occurring in both breast and lung cancers. A 55-year-old woman was admitted to our hospital with unsteadiness while walking. The patient had a history of breast cancer two years previously. Chest computed tomography revealed a 4.6 cm × 3.6 cm mass in the right lung, which was diagnosed as small-cell lung cancer (SCLC). Blood test was positive for anti-Yo antibodies, and the cerebrospinal fluid was positive for both anti-Yo and anti-Hu antibodies, and the neurological symptoms were considered to be related to the paraneoplasm. The patient was treated with a course of intravenous immunoglobulin, without noticeable improvement. After being discharged from hospital, the patient underwent regular chemotherapy for SCLC and periodic reviews. The patient's neurological symptoms continued to deteriorate at the follow-up visit in April 2021.
This case suggests the possibility of two types of tumors appearing simultaneously with two paraneoplastic antibodies. The clinical appearance of two or more paraneoplastic tumors requires additional attention.
副肿瘤性神经系统综合征(PNS)是癌症患者中一种罕见的并发症。PNS可影响中枢、外周、自主神经系统、神经肌肉接头或肌肉,并引起各种神经症状。抗Yo抗体阳性的神经副肿瘤和抗Hu抗体阳性的神经副肿瘤较为常见,但两种类型同时存在的情况在文献中尚未见报道。
在此,我们报告一例罕见的同时发生于乳腺癌和肺癌的副肿瘤性神经病变病例。一名55岁女性因行走不稳入院。该患者两年前有乳腺癌病史。胸部计算机断层扫描显示右肺有一个4.6 cm×3.6 cm的肿块,诊断为小细胞肺癌(SCLC)。血液检查抗Yo抗体呈阳性,脑脊液抗Yo和抗Hu抗体均呈阳性,神经症状被认为与副肿瘤有关。患者接受了一个疗程的静脉注射免疫球蛋白治疗,但无明显改善。出院后,患者接受了SCLC的常规化疗并定期复查。在2021年4月的随访中,患者的神经症状持续恶化。
该病例提示两种肿瘤可能同时出现并伴有两种副肿瘤抗体。两种或更多种副肿瘤性肿瘤的临床表现需要格外关注。